Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step
Anti-viral small molecules are currently lacking for treating coronavirus infection. The long development timescales for such drugs are a major problem, but could be shortened by repurposing existing drugs. We therefore screened a small library of FDA-approved compounds for potential severe acute re...
Enregistré dans:
Auteurs principaux: | Shiu-Wan Chan, Talha Shafi, Robert C. Ford |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f2dd9d95e53d41e08c051f48bd9646ae |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
par: Aaya Nassar, et autres
Publié: (2021) -
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
par: Enya Qing, et autres
Publié: (2021) -
Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
par: Balkrishna A, et autres
Publié: (2021) -
SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
par: Palaniyandi Velusamy, et autres
Publié: (2021) -
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells
par: Barbara Storti, et autres
Publié: (2021)